Gino K. In
机构：University of Southern California · ORCID：0000-0002-7060-5123
发表论文 147 篇 · 总被引 2109 次 · h-index 19
代表论文
- RP1 Combined With Nivolumab in Advanced Anti–PD-1–Failed Melanoma (IGNYTE) (2025 · Journal of Clinical Oncology · 被引 41)
- Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial (2025 · Nature Medicine · 被引 6)
- A case of cutaneous angiosarcoma with intradermal metastases responding to PD-1 inhibition-based immunotherapy (2025 · JAAD Case Reports · 被引 1)
- Erratum: Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301) (2025 · Journal of Clinical Oncology · 被引 1)
- MATRiX: A randomized phase II trial of tuvusertib (ATR inhibitor) with or without avelumab in advanced anti-PD(L)-1 refractory Merkel cell carcinoma. (2026 · Journal of Clinical Oncology)
- A 3-year landmark overall survival analysis of RP1 plus nivolumab in patients with anti–PD-1–failed melanoma from the IGNYTE clinical trial. (2026 · Journal of Clinical Oncology)